Cargando…

Par-4 prevents breast cancer recurrence

Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hebbar, Nikhil, Shrestha-Bhattarai, Tripti, Rangnekar, Vivek M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978615/ https://www.ncbi.nlm.nih.gov/pubmed/24164776 http://dx.doi.org/10.1186/bcr3562

Ejemplares similares

Arylquins Target Vimentin to Trigger Par-4 Secretion for Tumor Cell Apoptosis
por: Burikhanov, Ravshan, et al.
Publicado: (2014)

GRP78 Is a Targetable Receptor on Cancer and Stromal Cells
por: Araujo, Nathalia, et al.
Publicado: (2018)

Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity
por: Araujo, Nathalia, et al.
Publicado: (2022)

Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis
por: Burikhanov, Ravshan, et al.
Publicado: (2017)

Needles in a haystack: finding recurrent genomic changes in breast cancer
por: Cidado, Justin, et al.
Publicado: (2012)

COVID-19: a potential driver of immune-mediated breast cancer recurrence?
por: Francescangeli, Federica, et al.
Publicado: (2020)

Aspirin and breast cancer prevention – a link to ER status
por: Tait, Catherine R
Publicado: (2004)

Morel-Lavallée Lesion Contour Deformity: Quilting Sutures to Prevent Recurrent Seroma after Resection
por: Read, Jazlyn, et al.
Publicado: (2017)

Human breast milk: is it the best milk to prevent HIV transmission?
por: Palma, Paolo
Publicado: (2016)

Using Drains to Prevent Seroma Formation after Breast Surgery
por: Farrell, Leo D.
Publicado: (2019)

Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT
por: Parvani, Jenny G, et al.
Publicado: (2013)

MEK inhibition as a strategy for targeting residual breast cancer cells with low DUSP4 expression
por: Rottenberg, Sven, et al.
Publicado: (2012)

Amping up estrogen receptors in breast cancer
por: Fowler, Amy M, et al.
Publicado: (2007)

Misuse of Antipyretic Amid Fear of COVID-19 Vaccine
por: Gautam, Arun, et al.
Publicado: (2022)

For You and Your Baby (4YYB): Adapting the Centers for Disease Control and Prevention’s Text4Baby Program for Saudi Arabia
por: Bahanshal, Soha, et al.
Publicado: (2017)

A prophylactic vaccine for breast cancer?
por: Watson, Christine J, et al.
Publicado: (2010)

Are breast cancers driven by fusion genes?
por: Edwards, Paul AW, et al.
Publicado: (2012)

The role of single nucleotide polymorphisms in breast cancer metastasis
por: Rae, James M, et al.
Publicado: (2008)

Using Social Media to Target Cancer Prevention in Young Adults: Viewpoint
por: Sarkar, Urmimala, et al.
Publicado: (2018)

Inequities towards leprosy-affected people: A challenge during COVID-19 pandemic
por: Mahato, Sharika, et al.
Publicado: (2020)

Elf5 - breast cancer's little helper
por: Frend, Hayley T, et al.
Publicado: (2013)

Introducing the concept of breast cancer stem cells
por: Waterworth, Alison
Publicado: (2004)

Tracking the genomic evolution of breast cancer metastasis
por: Zecchin, Davide, et al.
Publicado: (2010)

Impact of microbiota on breast cancer hormone therapy
por: Terrisse, Safae, et al.
Publicado: (2023)

Emerging Technologies for Cancer Prevention and Other Population Health Challenges
por: Eng, Thomas R
Publicado: (2005)

Breast cancer brain metastases: evidence for neuronal-like adaptation in a ‘breast-to-brain’ transition?
por: Van Swearingen, Amanda ED, et al.
Publicado: (2014)

Quackery in Dental Practice in Nepal
por: Humagain, Manoj, et al.
Publicado: (2020)

Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India
por: Kaur, Prabhdeep, et al.
Publicado: (2017)

Breast cancer metastasis: a microRNA story
por: Negrini, Massimo, et al.
Publicado: (2008)

Cannibalism, cell survival, and endocrine resistance in breast cancer
por: Clarke, Robert
Publicado: (2011)

BRCA1: linking HOX to breast cancer suppression
por: Jin, Kideok, et al.
Publicado: (2010)

BOLERO-2 - will this change practice in advanced breast cancer?
por: Johnston, Stephen RD
Publicado: (2012)

The breast cancer somatic 'muta-ome': tackling the complexity
por: Teschendorff, Andrew E, et al.
Publicado: (2009)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

Mammographic density as a mediator for breast cancer risk: analytic approaches
por: VanderWeele, Tyler J, et al.
Publicado: (2012)

Pregnancy offers new insights into mechanisms of breast cancer risk and resistance
por: Jerry, D Joseph, et al.
Publicado: (2013)

Targeting RET–interleukin-6 crosstalk to impair metastatic dissemination in breast cancer
por: Morandi, Andrea, et al.
Publicado: (2014)

Establishing the role of the gut microbiota in susceptibility to recurrent urinary tract infections
por: Worby, Colin J., et al.
Publicado: (2022)

Obesity hormone leptin: a new target in breast cancer?
por: Surmacz, Eva
Publicado: (2007)

A quantum leap in our knowledge of breast cancer mutations
por: Caldas, Carlos, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6idsbn9eqorsk3nb4h5mb5de2c